Search

Hutchison China MediTech Ltd ADR

Uždarymo kaina

SektoriusSveikatos priežiūra

10.96 0.09

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

10.34

Max

10.99

Pagrindiniai rodikliai

By Trading Economics

Pajamos

978K

Pardavimai

135M

P/E

Sektoriaus vid.

4.272

62.58

Pelno marža

0.722

Darbuotojai

1,796

EBITDA

-14M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+35.06% upside

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

1.9B

Ankstesnė atidarymo kaina

10.87

Ankstesnė uždarymo kaina

10.96

Naujienos nuotaikos

By Acuity

100%

0%

322 / 340 reitingas Healthcare

Hutchison China MediTech Ltd ADR Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-07-24 23:51; UTC

News

Tenet Healthcare reported second-quarter earnings of $6.12 per share, exceeding estimates. Shares are trading higher in after-market hours following the strong results.

2026-07-24 23:46; UTC

News

HF Sinclair Corp has filed a lawsuit against the EPA over biofuel blending delays. Shares rose during after-market hours, maintaining a strong monthly performance.

2026-07-24 23:41; UTC

News

Kinsale Capital Group reported Q2 earnings of $5.54 per share, exceeding estimates, with revenue of $548.5 million, driving shares higher in after-market trading.

2026-07-24 23:41; UTC

Macro News
ETF Constituents
News

The Vanguard Information Technology ETF is higher in after-market hours, supported by key holdings like Apple and Qualcomm, despite broader market declines.

2026-07-24 23:41; UTC

News

Datadog Inc. is higher in after-market trading, benefiting from steady quarter-over-quarter revenue growth despite being surpassed by CoreWeave in total revenue.

2026-07-24 23:41; UTC

News

Boeing Co shares advanced in after-market hours, supported by a $695 billion backlog and positive analyst outlook on growth potential.

2026-07-24 23:36; UTC

News

KKR & Co Inc shares are lower in after-market hours following a $238.954 million share sale, reflecting potential liquidity concerns and capital allocation shifts.

2026-07-24 23:31; UTC

News

Interactive Brokers Group reported a 77% pre-tax profit margin but shares are lower in after-market hours amid concerns over rising interest rates and profitability.

2026-07-24 23:21; UTC

News
Social Media

Micron Technology Inc shares are declining in after-market trading amid concerns over potential pricing pressures in the cyclical memory chip market.

2026-07-24 23:21; UTC

Social Media
News

Warner Bros Discovery shares are lower in after-market trading as merger plans with Paramount Skydance are postponed until June 2027 amid legal challenges.

2026-07-24 23:21; UTC

News

Baker Hughes Co shares rose in after-market hours after a decrease in the active rig count, which fell to 587, the lowest since mid-July.

2026-07-24 23:16; UTC

News

CS PowerTech has launched its photovoltaic cell facility in Indiana, boosting Canadian Solar's U.S. manufacturing capabilities. Shares are higher in after-market trading.

2026-07-24 23:16; UTC

News

Liberty Energy reported Q2 revenue of $1.19 billion, exceeding estimates. Shares are higher in after-market trading following the earnings release.

2026-07-24 23:06; UTC

News

American Airlines Group Inc shares are lower in after-market hours following weaker profit guidance for the third quarter amid rising fuel costs.

2026-07-24 23:01; UTC

ETF Constituents
News

Vanguard Growth ETF advances in after-market trading, supported by contributions from Apple, Uber, and Applied Materials, following three lower daily closes.

2026-07-24 23:01; UTC

News

Elme Communities announced property sales totaling $294 million and revised liquidating distributions to $16.41 to $16.61 per share, trading higher in after-market hours.

2026-07-24 23:01; UTC

News

CACI International Inc. shares declined in after-market trading, influenced by a downturn in the Research & Consulting Services sub-sector.

2026-07-24 23:01; UTC

News

Emerson Electric Co shares are lower in after-market trading amid mixed market sentiment influenced by geopolitical tensions and new tariffs from the Trump administration.

2026-07-24 23:01; UTC

News

Carrier Global Corp shares declined in after-market hours following the appointment of PTC's Neil Barua to its board, effective immediately.

2026-07-24 23:01; UTC

News

Boston Scientific shares are higher in after-market hours despite a safety alert from the FDA regarding its ENROUTE Transcarotid Neuroprotection System catheters.

2026-07-24 22:22; UTC

News
Social Media

Uber shares are higher in after-market hours amid intensifying discussions about its partnership with Waymo and potential regulatory moves in the autonomous vehicle sector.

2026-07-24 22:02; UTC

News

ServiceNow shares are lower in after-market trading despite reporting $4 billion in revenue and raising full-year subscription guidance amid ongoing sector concerns.

2026-07-24 22:01; UTC

News
Social Media

Booz Allen Hamilton reported Q1 fiscal 2027 adjusted EPS of $1.81, exceeding expectations, and provided optimistic revenue guidance, boosting shares higher in after-market hours.

2026-07-24 21:41; UTC

News

Tractor Supply Co shares are lower in after-market hours, continuing a decline amid broader market volatility linked to geopolitical tensions and oil supply concerns.

2026-07-24 21:31; UTC

News

Embecta Corp is facing a securities class action lawsuit for allegedly misleading investors about its fiscal results, contributing to lower after-market hours trading.

2026-07-24 21:01; UTC

News

Golub Capital Bdc Inc reported a net asset value of $4.5 billion and is conducting a public offering of up to $10 billion in shares.

2026-07-24 21:01; UTC

News

Hercules Capital Inc's shares are lower after the company closed a $325 million note offering, with proceeds for debt repayment and investments.

2026-07-24 21:01; UTC

News

MetroCity Bankshares reported second-quarter net income of $22.1 million, missing expectations. Shares are higher in after-market trading, continuing a recent upward trend.

2026-07-24 20:07; UTC

Social Media
Correlated Moves
News

iShares Core U.S. Aggregate Bond ETF is gaining as major indices rebound amid lower crude oil prices and inflation concerns. The ETF's yield is 4.99%.

2026-07-24 20:07; UTC

News
Correlated Moves

Lovesac Co shares are lower as analysts express skepticism, citing slow revenue growth and weak free cash flow margins. The consensus price target is $24.17.

Akcijų palyginimas

Kainos pokytis

Hutchison China MediTech Ltd ADR Prognozė

Kainos tikslas

By TipRanks

35.06% į viršų

12 mėnesių prognozė

Vidutinis 14.87 USD  35.06%

Aukščiausias 17 USD

Žemiausias 13.6 USD

Remiantis 3 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Hutchison China MediTech Ltd ADR kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

3 ratings

1

Pirkti

2

Laikyti

0

Parduoti

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Hutchison China MediTech Ltd ADR

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in Hong Kong and internationally. The company develops Savolitinib for the treatment of non-small cell lung cancer (NSCLC), papillary renal cell carcinoma (RCC), and gastric cancer (GC); and Fruquintinib, an inhibitor for colorectal cancer (CRC), breast cancer, gastric cancer, microsatellite stable-CRC endometrial cancer (EMC), NSCLC, RCC, gastrointestinal, cervical, and solid tumors. It also develops Surufatinib, which is used for the treatment of pancreatic neuroendocrine tumor (NET), non-pancreatic NET, neuroendocrine carcinoma, SCLC, biliary tract cancer, and solid tumors; and Sovleplenib that treats hematological cancers and certain chronic immune diseases. In addition, it develops Tazemetostat for the treatment of certain epithelioid sarcoma and follicular lymphoma patients; HMPL-306, an inhibitor for hematological malignancies, gliomas, chondrosarcomas, cholangiocarcinomas, and solid tumors; HMPL-760, a Bruton's tyrosine kinase inhibitor; HMPL-453 for intrahepatic cholangiocarcinoma and solid tumors; HMPL-295 and HMPL-415 for solid tumors; HMPL-653 for metastatic solid tumors and tenosynovial giant cell tumors; and HMPL-A83 for the treatment of malignant neoplasms. It has collaboration agreements with AstraZeneca AB (publ), Lilly (Shanghai) Management Company Limited, Takeda, BeiGene Ltd., Inmagene Biopharmaceuticals Co. Ltd., Innovent Biologics Co., Inc., Genor Biopharma Co. Ltd., Shanghai Junshi Biosciences Co. Ltd., and Epizyme, Inc. The company was formerly known as Hutchison China MediTech Limited and changed its name to HUTCHMED (China) Limited in May 2021. HUTCHMED (China) Limited was incorporated in 2000 and is headquartered in Hong Kong, Hong Kong.
help-icon Live chat